USA - NASDAQ:PTCT - US69366J2006 - Common Stock
Taking everything into account, PTCT scores 6 out of 10 in our fundamental rating. PTCT was compared to 536 industry peers in the Biotechnology industry. Both the profitability and the financial health of PTCT get a neutral evaluation. Nothing too spectacular is happening here. PTCT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes PTCT very considerable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 23.89% | ||
ROE | N/A | ||
ROIC | 34.54% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 49.7% | ||
PM (TTM) | 35.65% | ||
GM | 97.09% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 3.44 | ||
Altman-Z | 2.13 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.62 | ||
Quick Ratio | 3.57 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.63 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 7.51 | ||
EV/EBITDA | 5.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
65.95
-0.87 (-1.3%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.63 | ||
Fwd PE | N/A | ||
P/S | 2.97 | ||
P/FCF | 7.51 | ||
P/OCF | 7.43 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 5.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 23.89% | ||
ROE | N/A | ||
ROCE | 43.72% | ||
ROIC | 34.54% | ||
ROICexc | 4029.4% | ||
ROICexgc | N/A | ||
OM | 49.7% | ||
PM (TTM) | 35.65% | ||
GM | 97.09% | ||
FCFM | 39.52% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 3.44 | ||
Debt/EBITDA | 2.36 | ||
Cap/Depr | 26.13% | ||
Cap/Sales | 0.42% | ||
Interest Coverage | 203.36 | ||
Cash Conversion | 77.86% | ||
Profit Quality | 110.85% | ||
Current Ratio | 3.62 | ||
Quick Ratio | 3.57 | ||
Altman-Z | 2.13 |